Back to search

Article

A Clinical Risk Score for Predicting Anti-Tuberculosis Drug-Induced Liver Injury During Standard Treatment for Drug-Susceptible Tuberculosis

2026-08-31

Abstract excerpt

<title>Abstract</title> <p> Background The standard 2HRZE/4HR regimen is recommended for the treatment of drug-susceptible tuberculosis (DS-TB). Anti-tuberculosis drug-induced liver injury (ATDILI) is a common and clinically important adverse drug reaction that can compromise treatment continuity and adversely affect treatment outcomes. Currently, no practical clinical tool is available to predict ATDILI risk i...

Identifiers and source

Literature Corpus work
dadd873a-bee2-5edf-b3be-8b22b064d7dc
DOI
10.21203/rs.3.rs-10336666/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Clinical Risk Score for Predicting Anti-Tuberculosis Drug-Induced Liver Injury During Standard Treatment for Drug-Susceptible TuberculosisDOI 10.21203/rs.3.rs-10336666/v1
Incidence and associated risk factors of antituberculosis drug induced hepatotoxicity among TB patientsSemantic proximity
NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic CohortSemantic proximity
Antituberculosis Drug-Induced Adverse Events in the Liver, Kidneys, and Blood: Clinical Profiles and Pharmacogenetic Predictors.Semantic proximity
The role of NAT2 genetic variants in anti-tuberculosis drug-induced liver injury (AT-DILI): a meta-analysis.Semantic proximity
NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study.Semantic proximity
NAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis.Semantic proximity
NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis.Semantic proximity
Genetic Variants at the NAT2 and HLA-DOA are Associated With Anti-Tuberculosis Drug-Induced Liver Injury Susceptibility and Clinical Manifestations in Western Chinese Populations.Semantic proximity
Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic PerspectiveSemantic proximity
NAT2 and CYP2E1 polymorphisms and antituberculosis drug-induced hepatotoxicity in Peruvian patients.Semantic proximity
Assessment of Pharmacotherapy and Clinical Outcomes of Treatment for the Development of Cardiovascular Disease among Tuberculosis PatientsSemantic proximity
Pharmacogenomic insights into tuberculosis treatment shows the NAT2 genetic variants linked to hepatotoxicity risk: a systematic review and meta-analysis.Semantic proximity
Select a neighboring publication to make it the new centre.